Thiosemicarbazones as anti-virals and immunopotentiators
US7521062B2 · kind B2 · utility
0Cited by
14References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 29, 2003 |
| Grant date | Apr 21, 2009 |
| Priority date | — |
| Expiry date | Jul 22, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55511
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by administering the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.